index - Myopathies inflammatoires & thérapies innovantes ciblées

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Sphingosine-1-phosphate AAV antibody Anémie hémolytique Cytokines Adverse drug reactions Bioelectrical impedance analysis Case reports Middle Aged Inflammation Biopsy B-lymphocyte Analyses multidimensionnelles Deep immune profiling Humans Lysosomal storage diseases Myopathy Adult AAV vector Dependovirus/genetics/immunology Mass cytometry Biomarkers Antibodies Anti-agalsidase antibodies Arthritis IMNM Myositis Biomarker Fabry disease Cardio-oncology AAV humoral immunity Adeno-associated vector Anti-interleukin-6 Anti-synthetase syndrome Acid-alpha-glucosidase Adeno-associated virus Machine learning Abnormal movement Antibody responses Anti-IgE IgG Aged Muscle Immunotherapy Anti-Mi2 Antisynthetase syndrome Interferon Aldostérone Antisynthetase Inclusion body myositis IBM Autoantibody Assisted communication devices Cancer Antisynthétase Polymyositis Inflammatory myopathy Inborn errors of metabolism Autoantibodies Biomarqueurs Myositis and muscle disease Female Agalsidase Anticorps spécifique des myosites Adolescence Dermatomyositis Outcome measures Active Pharmacology Systems biology Anticorps anti-agalsidase Auto‐antibodies DM Amyotrophy Animals B cell homeostasis Multidisciplinarity Data integration COVID-19 Prognosis Autoimmunity Anti‐mitochondrial antibodies Antiphospholipid syndrome Gene therapy Auto-immunité Anti-drug antibodies Skeletal muscle AAV Acute Kidney Injury/epidemiology/etiology AAV vectors Adeno-associated virus vector Idiopathic inflammatory myopathies Adjudication Autoimmune diseases Interstitial lung disease Anti-MDA5 autoantibodies Male Auto-antibodies Myocarditis Aldosterone Amyotrophic lateral sclerosis Immune checkpoint inhibitors